AlphaVax, Inc. (AlphaVax)

Oncology Corporate Profile

HQ Location

P.O. Box 110307
Research Triangle Park, NC 27709

Company Description

AlphaVax, Inc. (AVX, Research Triangle Park, NC), a privately-held, clinical-stage biopharmaceutical company, has used its proprietary alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
AVX901immunotherapyBreast cancerI
AVX901immunotherapyColorectal cancerI
AVX901immunotherapyProstate cancerI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display